AU2369801A - Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation - Google Patents

Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation

Info

Publication number: AU2369801A
Authority: AU; Australia
Prior art keywords: additive; pharmaceutical composition; transdermally administering; enhances permeation; administering hormones
Prior art date: 2000-01-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU23698/01A

Inventor

Achim Berthold

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

LTS Lohmann Therapie Systeme AG

Original Assignee

LTS Lohmann Therapie Systeme AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-07

Filing date

2000-12-23

Publication date

2001-07-16

2000-12-23 Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG

2001-07-16 Publication of AU2369801A publication Critical patent/AU2369801A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Dermatology (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU23698/01A 2000-01-07 2000-12-23 Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation Abandoned AU2369801A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE2000100333 DE10000333A1 (en)	2000-01-07	2000-01-07	Pharmaceutical composition for the transdermal administration of hormones with a permeation-improving additive
DE10000333		2000-01-07
PCT/EP2000/013268 WO2001049273A2 (en)	2000-01-07	2000-12-23	Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation

Publications (1)

Publication Number	Publication Date
AU2369801A true AU2369801A (en)	2001-07-16

Family

ID=7626866

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU23698/01A Abandoned AU2369801A (en)	2000-01-07	2000-12-23	Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation

Country Status (4)

Country	Link
AR (1)	AR026797A1 (en)
AU (1)	AU2369801A (en)
DE (1)	DE10000333A1 (en)
WO (1)	WO2001049273A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2873371B1 (en) *	2004-07-26	2008-07-04	Sod Conseils Rech Applic	NEW METHOD OF SYNTHESIS OF 2,5 DIOXANE 1,4 DIONES
DE102006050558B4 (en) *	2006-10-26	2009-03-26	Lts Lohmann Therapie-Systeme Ag	Transdermal therapeutic system containing norelgestromin for contraception and hormone replacement
DE102010004769A1 (en)	2009-07-08	2011-01-13	Kuchenbecker, Manfred, Dr.-Ing.	Reluctance generator for feed in alternating or three-phase current constant voltage and constant frequency at variable speed, is provided with multiple uniform oppositely displaced partial phases for phase of output voltage
EP2812372B1 (en)	2012-02-09	2018-09-26	Novus International Inc.	Heteroatom containing cyclic dimers
US9452143B2 (en)	2012-07-12	2016-09-27	Novus International, Inc.	Matrix and layer compositions for protection of bioactives
KR20160040207A (en)	2013-08-09	2016-04-12	더 케무어스 컴퍼니 에프씨, 엘엘씨	Skin care compositions having cyclic diesters and methods thereof
US10584306B2 (en)	2017-08-11	2020-03-10	Board Of Regents Of The University Of Oklahoma	Surfactant microemulsions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GR1002079B (en) *	1994-07-26	1995-12-05	Lavipharm A E	System of a special structure and composition for the rapid transdermal administration of oestrogens.
WO1996040087A2 (en) *	1995-06-07	1996-12-19	Cygnus, Inc.	Pressure sensitive acrylate adhesive composition cross-linked with aluminum acetylacetonate and containing a drug having a reactive aromatic hydroxyl group

2000
- 2000-01-07 DE DE2000100333 patent/DE10000333A1/en not_active Withdrawn
- 2000-12-23 AU AU23698/01A patent/AU2369801A/en not_active Abandoned
- 2000-12-23 WO PCT/EP2000/013268 patent/WO2001049273A2/en not_active Ceased
2001
- 2001-01-05 AR ARP010100041A patent/AR026797A1/en unknown

Also Published As

Publication number	Publication date
WO2001049273A3 (en)	2002-05-23
AR026797A1 (en)	2003-02-26
DE10000333A1 (en)	2001-07-19
WO2001049273A2 (en)	2001-07-12

Similar Documents

Publication	Publication Date	Title
AUPQ867700A0 (en)	2000-08-03	Delivering multimedia descriptions
AU6275601A (en)	2001-11-26	Stable polymeric micelle-type drug composition and method for the preparation thereof
AU7361400A (en)	2001-04-10	Prodrugs for liver specific drug delivery
IL149186A0 (en)	2002-11-10	Pharmaceutical compositions providing enhanced drug concentrations
AU2001235009A1 (en)	2001-11-01	Drug delivery apparatus
WO2005065318A3 (en)	2005-12-15	Effervescent oral opiate dosage form
AU2002236647A1 (en)	2002-07-01	Method and device for administering medication and/or placebo
AU2001244713A1 (en)	2001-10-15	Transporters and drug delivery system by using the same
ZA200410211B (en)	2005-09-06	Quinuclidine derivatives and pharmaceutical compositions containing the same.
AU2001232020A1 (en)	2001-08-20	Floating drug delivery composition
ATE287264T1 (en)	2005-02-15	ORAL MEDICINAL PRODUCTS CONTAINING BUPRENORPHINE
AU2001272293A1 (en)	2002-06-20	Device for administering an injectable product
AU2001276831A1 (en)	2002-01-02	Delivery vehicle composition and methods for delivering antigens and other drugs
WO2002011724A3 (en)	2002-08-15	Neuroprotective 2-pyridinamine compositions and related methods
AU2000272858A1 (en)	2001-08-14	Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
AU2369801A (en)	2001-07-16	Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation
HK1054033A1 (en)	2003-11-14	4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
AU2001224818A1 (en)	2002-07-18	Device for administering liquids
AU2001258443A1 (en)	2001-11-20	Drug delivery device, especially for the delivery of gestodene
AU2002222750A1 (en)	2002-06-24	Pharmaceutical composition for intramuscular injection containing loxoprofen
AU2001258442A1 (en)	2001-11-20	Drug delivery device, especially for the delivery of levonorgestrel
AU5072000A (en)	2000-12-28	Pharmaceutical composition for nasally administering water-soluble active substances
AU3926000A (en)	2000-10-23	Methods and compositions for drug delivery
AU2003251643A1 (en)	2004-02-23	Pharmaceutical compositions containing keto-acids for endoperitoneal administration
AU2882699A (en)	1999-09-15	Stabilizing composition for pharmaceutical dosage forms

Legal Events

Date	Code	Title	Description
2003-12-18	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase